1. Analysis of Infections and All‐Cause Mortality in Phase II, Phase III, and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis1. Issue 11 (November 2014) Authors: Cohen, Stanley; Radominski, Sebastião C.; Gomez‐Reino, Juan J.; Wang, Lisy; Krishnaswami, Sriram; Wood, Susan P.; Soma, Koshika; Nduaka, Chudi I.; Kwok, Kenneth; Valdez, Hernan; Benda, Birgitta; Riese, Richard Journal: Arthritis & rheumatology Issue: Volume 66:Issue 11(2014) Page Start: 2924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques. Issue 6 (25th January 2016) Authors: Conaghan, Philip G; Østergaard, Mikkel; Bowes, Michael A; Wu, Chunying; Fuerst, Thomas; van der Heijde, Désirée; Irazoque-Palazuelos, Fedra; Soto-Raices, Oscar; Hrycaj, Pawel; Xie, Zhiyong; Zhang, Richard; Wyman, Bradley T; Bradley, John D; Soma, Koshika; Wilkinson, Bethanie Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 6(2016) Page Start: 1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs. Issue 7 (14th August 2015) Authors: Charles-Schoeman, Christina; Burmester, Gerd; Nash, Peter; Zerbini, Cristiano A F; Soma, Koshika; Kwok, Kenneth; Hendrikx, Thijs; Bananis, Eustratios; Fleischmann, Roy Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 7(2016) Page Start: 1293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. Issue 10093 (29th July 2017) Authors: Fleischmann, Roy; Mysler, Eduardo; Hall, Stephen; Kivitz, Alan J; Moots, Robert J; Luo, Zhen; DeMasi, Ryan; Soma, Koshika; Zhang, Richard; Takiya, Liza; Tatulych, Svitlana; Mojcik, Christopher; Krishnaswami, Sriram; Menon, Sujatha; Smolen, Josef S Journal: Lancet Issue: Volume 390:Issue 10093(2017) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study. Issue 3 (27th February 2020) Authors: Calabrese, Leonard H.; Abud‐Mendoza, Carlos; Lindsey, Stephen M.; Lee, Sang‐Heon; Tatulych, Svitlana; Takiya, Liza; Iikuni, Noriko; Soma, Koshika; Luo, Zhen; Fleischmann, Roy Journal: Arthritis care & research Issue: Volume 72:Issue 3(2020) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib. Issue 5 (11th March 2020) Authors: Winthrop, Kevin L; Wouters, Ann; Choy, Ernest H; Chen, Connie; Biswas, Pinaki; Wang, Lisy; Soma, Koshika; Needle, Elie; Valdez, Hernan; Rigby, William FC Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 5(2020) Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial. Issue 2 (1st October 2019) Authors: Strand, Vibeke; Mysler, Eduardo; Moots, Robert J; Wallenstein, Gene V; DeMasi, Ryan; Gruben, David; Soma, Koshika; Iikuni, Noriko; Smolen, Josef S; Fleischmann, Roy Journal: RMD open Issue: Volume 5:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis. Issue 9 (6th August 2019) Authors: Charles‐Schoeman, Christina; DeMasi, Ryan; Valdez, Hernan; Soma, Koshika; Hwang, Lie‐Ju; Boy, Mary G.; Biswas, Pinaki; McInnes, Iain B. Journal: Arthritis & rheumatology Issue: Volume 71:Issue 9(2019) Page Start: 1450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis. Issue 4 (20th March 2015) Authors: Winthrop, Kevin L; Silverfield, Joel; Racewicz, Arthur; Neal, Jeffrey; Lee, Eun Bong; Hrycaj, Pawel; Gomez-Reino, Juan; Soma, Koshika; Mebus, Charles; Wilkinson, Bethanie; Hodge, Jennifer; Fan, Haiyun; Wang, Tao; Bingham, Clifton O Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 4(2016) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Effectiveness of Zoster Vaccine in Patients Subsequently Treated With Tofacitinib: 748. (October 2017) Authors: Winthrop, Kevin L.; Wouters, Ann; Choy, Ernest H.; Nduaka, Chudy I.; Biswas, Pinaki; Wang, Lisy; Hodge, Jennifer A.; Lazariciu, Irina; Soma, Koshika; Mojcik, Christopher F.; Rigby, William F.C. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗